Core Laboratories INC /DE/ DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Core Laboratories Inc. announces its 2026 annual meeting of shareholders to address director re-election, auditor ratification, and advisory vote on executive compensation, alongside disclosures on financial performance and geopolitical risks.
NYSE
Core Laboratories Inc. will hold its annual shareholder meeting on May 21, 2025, to elect directors, ratify the appointment of KPMG LLP as independent accountants, and approve executive compensation.
NYSE
Core Laboratories Inc. sets date for its 2025 annual shareholder meeting and outlines key proposals, including director elections, auditor ratification, and executive compensation approval.
NYSE
Core Laboratories Inc. will hold its annual shareholder meeting on May 8, 2024, to vote on director elections, auditor ratification, executive compensation, and an amendment to the long-term incentive plan.
NYSE
Core Laboratories is asking shareholders to approve an amendment and restatement of its 2020 Long-Term Incentive Plan to increase the number of authorized shares and extend the plan's term.